JPMorgan Surpasses 5% Voting Rights in UK's Spire Healthcare Group
JPMorgan Chase & Co. has surpassed the 5% voting rights threshold in Spire Healthcare Group plc, a UK-listed private hospital operator. This milestone was achieved on September 25, 2026, and triggered a regulatory disclosure filed on September 29, 2026.
The American financial institution now holds a total of 5.033299% of Spire Healthcare's voting rights, comprising both direct shares and cash-settled equity swaps managed by J.P. Morgan Securities PLC. The largest single swap position covers 7,777,948 voting rights, equivalent to 1.931163%, while another significant swap expiring on February 22, 2027, covers 5,903,116 voting rights, representing 1.465667%.
The disclosure reveals that JPMorgan's stake in Spire Healthcare is split between direct voting rights attached to shares and cash-settled equity swaps. The majority of the exposure comprises these cash-settled instruments, which do not confer the right to acquire physical shares but are reportable due to their analogous economic impact on voting rights exposure.